Study: Generic HIV drugs could save nearly $1B in first year

01/15/2013 | MedPage Today (free registration)

Switching all eligible patients to generic HIV drugs could save the U.S. $920 million in the first year the drugs are available, researchers at Massachusetts General Hospital report in the Annals of Internal Medicine, although they note that the brand-name single-pill combination drug is the best choice for first-line treatment for improved adherence and efficacy.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID